Skip to content

Role of Oral Selenium in Treatment of Respiratory Infections in Children.

Role Of Selenium In Acute Lower Respiratory Tract Infections In Children : A Double Blind Randomized Controlled Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/04/051842
Enrollment
120
Registered
2023-04-21
Start date
Unknown
Completion date
Unknown
Last updated
2023-05-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J22- Unspecified acute lower respiratory infection

Interventions

Intervention1: Sodium selenate: Dose for 6months-3years of age :20mcg(2 drops),dose for 4years-5years of age:30mcg(3drops)
route:oral
duration :daily for minimum 5 days or discharge whichever is later along with protocol based management of acute lower respiratory infection Control Intervention1: Placebo: placebo ,6months-3 years:2d

Sponsors

Rubeena Shaikh
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All patients of age group 6 months to 5 years, admitted with acute lower respiratory tract infections fulfilling any three of the following eligibility criteria will be enrolled : 1.fever and/or cough, 2.tachypnea for age :respiratory rate: 6months to 12 months >50/min, 13 months to 5 years >40/min., 3.accessory muscle use 4.wheeze and/or crepitation on auscultation.

Exclusion criteria

Exclusion criteria: All patients with 1.Severe acute malnutrition 2.Congenital heart disease 3.Chronic systemic illness 4.Gastrointestinal malformations 5.Patients on Micronutrient supplementation containing selenium

Design outcomes

Primary

MeasureTime frame
1.To study the time required for clinical recovery (defined as resolution of fever, absence of signs of respiratory distress, acceptance of oral feeds equivalent to pre-illness intake. 2.To determine the duration,FiO2 requirement and mode of oxygen delivery (ventilation, CPAP, nonrebreathing mask, facemask, nasal prongs).Timepoint: 5 days or discharge (whichever is earlier)

Secondary

MeasureTime frame
1.To document the duration of hospital stay.2. To study the side effect of selenium(if any).Timepoint: 5 days or discharge (whichever is earlier)

Countries

India

Contacts

Public ContactRubeena Shaikh

Government Medical College and Hospital ,Aurangabad.

drtruptijoshi@gmail.com7218137969

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 5, 2026